Latest News and Press Releases
Want to stay updated on the latest news?
-
MISSION VIEJO, CA--(Marketwired - May 16, 2016) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against fibrosis, inflammation,...
-
MISSION VIEJO, CA --(Marketwired - April 18, 2016) - Aeolus Pharmaceuticals (OTCQB: AOLS) AEOL 11114 Is Subject of Michael J Fox Foundation Research Grant Program ...
-
MISSION VIEJO, CA--(Marketwired - February 22, 2016) - Aeolus Pharmaceuticals, Inc.(OTCQB: AOLS), a biotechnology company developing compounds to protect against fibrosis, inflammation, nerve...
-
MISSION VIEJO, CA--(Marketwired - February 16, 2016) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against fibrosis, inflammation,...
-
MISSION VIEJO, CA--(Marketwired - December 18, 2015) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against radiological and...
-
MISSION VIEJO, CA--(Marketwired - December 15, 2015) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against fibrosis, inflammation,...
-
MISSION VIEJO, CA--(Marketwired - December 14, 2015) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against fibrosis, inflammation,...
-
MISSION VIEJO, CA--(Marketwired - November 04, 2015) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against fibrosis, inflammation, nerve damage...
-
MISSION VIEJO, CA--(Marketwired - November 02, 2015) - PRE-CLINICAL WORK UNDERWAY WITH IND FILING FOR PARKINSON'S DISEASE TARGETED IN 2017EFFICACY DEMONSTRATED IN TWO PARKINSON'S DISEASE MODELS...
-
MISSION VIEJO, CA--(Marketwired - August 18, 2015) - FINDINGS REPORTED BY DR. MANISHA PATELOF THE UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS, DEPARTMENT OF PHARMACEUTICAL SCIENCES AND PUBLISHED...